[go: up one dir, main page]

RU2003104538A - CEREBROPROTECTIVE AND NOOTROPIC MEDICINE "NOOTRIL" IN TABLETS, COVERED - Google Patents

CEREBROPROTECTIVE AND NOOTROPIC MEDICINE "NOOTRIL" IN TABLETS, COVERED

Info

Publication number
RU2003104538A
RU2003104538A RU2003104538/15A RU2003104538A RU2003104538A RU 2003104538 A RU2003104538 A RU 2003104538A RU 2003104538/15 A RU2003104538/15 A RU 2003104538/15A RU 2003104538 A RU2003104538 A RU 2003104538A RU 2003104538 A RU2003104538 A RU 2003104538A
Authority
RU
Russia
Prior art keywords
cerebroprotective
nootropic
nootril
tablets
medicine
Prior art date
Application number
RU2003104538/15A
Other languages
Russian (ru)
Other versions
RU2248203C2 (en
Inventor
Иван Антонович Мазур
Виталий Романович Стец
Николай Анатольевич Волошин
Игорь Федорович Беленичев
Зинаида Брониславовна Моряк
Тарас Андреевич Грошевой
Людмила Ивановна Кучеренко
Ирина Владимировна Сидорова
Original Assignee
Общество с ограниченной ответственностью Научно-производственное объединение "Фарматрон"
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью Научно-производственное объединение "Фарматрон" filed Critical Общество с ограниченной ответственностью Научно-производственное объединение "Фарматрон"
Priority to RU2003104538/15A priority Critical patent/RU2248203C2/en
Priority claimed from RU2003104538/15A external-priority patent/RU2248203C2/en
Publication of RU2003104538A publication Critical patent/RU2003104538A/en
Application granted granted Critical
Publication of RU2248203C2 publication Critical patent/RU2248203C2/en

Links

Claims (1)

Церебропротекторное и ноотропное лекарственное средство в таблетках, покрытых оболочкой, содержащее активный ингредиент - тиотриазолин и вспомогательные ингредиенты для формирования таблетки-ядра и нанесения на него оболочки, отличающееся тем, что в качестве активного ингредиента содержит пирацетам при следующем соотношении ингредиентов, мас.%:A cerebroprotective and nootropic drug in coated tablets containing the active ingredient - thiotriazoline and auxiliary ingredients for the formation of the tablet core and coating on it, characterized in that it contains piracetam as the active ingredient in the following ratio of ingredients, wt.%: Пирацетам 53,6-59Piracetam 53.6-59 Тиотриазолин 13,3-14,7Thiotriazoline 13.3-14.7 Вспомогательные ингредиенты ОстальноеAuxiliary ingredients Else
RU2003104538/15A 2003-02-14 2003-02-14 Cerebroprotective and nootropic medicinal agent "nootril" in envelope-covered tablet RU2248203C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003104538/15A RU2248203C2 (en) 2003-02-14 2003-02-14 Cerebroprotective and nootropic medicinal agent "nootril" in envelope-covered tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003104538/15A RU2248203C2 (en) 2003-02-14 2003-02-14 Cerebroprotective and nootropic medicinal agent "nootril" in envelope-covered tablet

Publications (2)

Publication Number Publication Date
RU2003104538A true RU2003104538A (en) 2004-08-27
RU2248203C2 RU2248203C2 (en) 2005-03-20

Family

ID=35454290

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003104538/15A RU2248203C2 (en) 2003-02-14 2003-02-14 Cerebroprotective and nootropic medicinal agent "nootril" in envelope-covered tablet

Country Status (1)

Country Link
RU (1) RU2248203C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2275910C2 (en) * 2004-02-26 2006-05-10 Акционерное общество "Галичфарм" Method for production of coated tablets having cerebroprotective, antioxydant, and noothropic action
RU2361591C1 (en) * 2007-10-03 2009-07-20 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") Anticonvulsant medical product
RU2445090C1 (en) * 2010-10-29 2012-03-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Agent possessing antiradical, cerebroprotective and antiischemic properties
RU2625754C1 (en) * 2016-06-15 2017-07-18 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Combined drug of anxiolithic, stress-protector, nootropic and antioxidant action

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757160B1 (en) * 1996-12-13 1999-03-12 Sanofi Sa 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES
RU2177783C1 (en) * 2001-02-02 2002-01-10 Общество С Ограниченной Ответственностью "Консорциум-Пик" Nootropic preparation

Similar Documents

Publication Publication Date Title
NO2025027I1 (en) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.
EA200400471A1 (en) ORAL DOSED FORM PROPIVERINA
BR0212921A (en) Fondant-based pharmaceutical composition
HUP0301972A2 (en) Active substance combination containing an opioid having a fentanyl-type structure and ketamine and pharmaceutical compositions containing it
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
WO2001041737A3 (en) Solid oral dosage form
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
MA26968A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINE MALEATE.
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
CA2325739A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
AU2001234114A1 (en) Drugs containing combined active ingredients
CA2361402A1 (en) Bis-sulfonamides
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
WO2005004915A3 (en) Compositions comprising meloxicam
WO2002024697A1 (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
WO2005117895A3 (en) Compositions comprising meloxicam
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
WO2003024933A1 (en) 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
CA2220019A1 (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation